: The development of an HIV-1 vaccine is dependent on the design of an antigen that will elicit a broad and potent neutralizing response. Only four antibodies have been identified with these desired neutralization properties. and one focus of our proposal is to use X-ray crystallography to determine structures of these antibodies in complex with peptide-based, carbohydrate or small molecule compounds designed for use as potential immunogens. In addition, we will investigate anti-HIV-1 antibodies with type-specific neutralization in order to obtain a better understanding of why anti-HIV antibodies display broad versus type-specific activity. Understanding the structural basis for these differences is critical for the design of an effective immunogen. We will supplement the very limited structural information available for the HIV-1 envelope glycoprotein gp120 by the production and structural study of different monomeric gp120 and trimeric gp140 constructs, alone or in complex with one or more anti-gp120 or anti-gp41 Fabs. The use of Fabs as tools for crystallization will also be exploited for the crystallization and structure determination of the HIV-1 viral infectivity factor (Vif) as a complex with a scFv or Vh domain. We will also determine structures for the gp41 fusion active core as a complex with the conformation specific antibody NC-1 and for the gp41 N-helical region with small molecule fusion inhibitors. These studies all have the common goal of providing essential structural information on HIV-1 proteins and anti-HIV-1 antibodies to help guide efforts in vaccine and inhibitor design. ? ?

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
AIDS Molecular and Cellular Biology Study Section (AMCB)
Program Officer
Basavappa, Ravi
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Scripps Research Institute
La Jolla
United States
Zip Code
Garces, Fernando; Lee, Jeong Hyun; de Val, Natalia et al. (2015) Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans. Immunity 43:1053-63
Garces, Fernando; Sok, Devin; Kong, Leopold et al. (2014) Structural evolution of glycan recognition by a family of potent HIV antibodies. Cell 159:69-79
Kong, Leopold; Lee, Jeong Hyun; Doores, Katie J et al. (2013) Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat Struct Mol Biol 20:796-803
Stanfield, Robyn L; Julien, Jean-Philippe; Pejchal, Robert et al. (2011) Structure-based design of a protein immunogen that displays an HIV-1 gp41 neutralizing epitope. J Mol Biol 414:460-76
Doores, Katie J; Fulton, Zara; Hong, Vu et al. (2010) A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity. Proc Natl Acad Sci U S A 107:17107-12
Pejchal, Robert; Gach, Johannes S; Brunel, Florence M et al. (2009) A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies. J Virol 83:8451-62
Bell, Christian H; Pantophlet, Ralph; Schiefner, Andre et al. (2008) Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization. J Mol Biol 375:969-78
Saphire, E O; Parren, P W; Barbas 3rd, C F et al. (2001) Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: an antibody that broadly neutralizes primary isolates of HIV-1. Acta Crystallogr D Biol Crystallogr 57:168-71